Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Daniel

Showing results (281-290 of 298) with videos related to

Pageof 30
Sort By:
Epigenetics|February 6, 2014
BET bromodomain proteins are required for glioblastoma cell proliferationChiara Pastori, Mark Daniel, Clara Penas, et al.
European Journal of Preventive Cardiology|October 17, 2018
Examining adherence to activity monitoring devices to improve physical activity in adults with cardiovascular disease: A systematic reviewTania S Marin, Constance Kourbelis, Jonathon Foote, et al.
BMJ Open|July 9, 2018
Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT): a protocol for a randomised factorial, double-blind, placebo-controlled trial of azithromycin, nitazoxanide and nicotinamideMark Daniel DeBoer, James A Platts-Mills, Rebecca J Scharf, et al.
Medical Sciences (Basel, Switzerland)|April 24, 2019
The Keeping on Track Study: Exploring the Activity Levels and Utilization of Healthcare Services of Acute Coronary Syndrome (ACS) Patients in the First 30-Days after Discharge from HospitalRobyn A Clark, Jonathon Foote, Vincent L Versace, et al.
Diabetes, Obesity & Metabolism|December 7, 2018
Testosterone therapy to prevent type 2 diabetes mellitus in at-risk men (T4DM): Design and implementation of a double-blind randomized controlled trialGary Wittert, Evan Atlantis, Carolyn Allan, et al.
Clinical Trials (London, England)|October 5, 2019
A high-volume, low-cost approach to participant screening and enrolment: Experiences from the T4DM diabetes prevention trialKaren Bracken, Anthony Keech, Wendy Hague, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2025
Developing Meaningful Score Differences for the Bayley-4 and Vineland-3 in Angelman Syndrome using a Delphi PanelSonya Powers, Katherine N Anderson, Wen-Hann Tan, et al.
BMJ Open|July 30, 2021
Treatment of tungiasis using a tea tree oil-based gel formulation: protocol for a randomised controlled proof-of-principle trialSolomon Abrha, Julia K Christenson, John McEwen, et al.
Journal of Clinical Epidemiology|May 4, 2019
Telephone call reminders did not increase screening uptake more than SMS reminders: a recruitment study within a trialKaren Bracken, Anthony Keech, Wendy Hague, et al.
The Journal of Clinical Endocrinology and Metabolism|January 30, 2025
Response to Letter to the Editor From Lin et al: "Testosterone Treatment, Weight Loss, and Health-Related Quality of Life and Psychosocial Function in Men: A 2-Year Randomized Controlled Trial"Mathis Grossmann, Kristy P Robledo, Mark Daniel, et al.
Pageof 30

Showing results (281-290 of 298) with videos related to

Sort By:
Pageof 30
Epigenetics|February 6, 2014
BET bromodomain proteins are required for glioblastoma cell proliferationChiara Pastori, Mark Daniel, Clara Penas, et al.
European Journal of Preventive Cardiology|October 17, 2018
Examining adherence to activity monitoring devices to improve physical activity in adults with cardiovascular disease: A systematic reviewTania S Marin, Constance Kourbelis, Jonathon Foote, et al.
BMJ Open|July 9, 2018
Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT): a protocol for a randomised factorial, double-blind, placebo-controlled trial of azithromycin, nitazoxanide and nicotinamideMark Daniel DeBoer, James A Platts-Mills, Rebecca J Scharf, et al.
Medical Sciences (Basel, Switzerland)|April 24, 2019
The Keeping on Track Study: Exploring the Activity Levels and Utilization of Healthcare Services of Acute Coronary Syndrome (ACS) Patients in the First 30-Days after Discharge from HospitalRobyn A Clark, Jonathon Foote, Vincent L Versace, et al.
Diabetes, Obesity & Metabolism|December 7, 2018
Testosterone therapy to prevent type 2 diabetes mellitus in at-risk men (T4DM): Design and implementation of a double-blind randomized controlled trialGary Wittert, Evan Atlantis, Carolyn Allan, et al.
Clinical Trials (London, England)|October 5, 2019
A high-volume, low-cost approach to participant screening and enrolment: Experiences from the T4DM diabetes prevention trialKaren Bracken, Anthony Keech, Wendy Hague, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2025
Developing Meaningful Score Differences for the Bayley-4 and Vineland-3 in Angelman Syndrome using a Delphi PanelSonya Powers, Katherine N Anderson, Wen-Hann Tan, et al.
BMJ Open|July 30, 2021
Treatment of tungiasis using a tea tree oil-based gel formulation: protocol for a randomised controlled proof-of-principle trialSolomon Abrha, Julia K Christenson, John McEwen, et al.
Journal of Clinical Epidemiology|May 4, 2019
Telephone call reminders did not increase screening uptake more than SMS reminders: a recruitment study within a trialKaren Bracken, Anthony Keech, Wendy Hague, et al.
The Journal of Clinical Endocrinology and Metabolism|January 30, 2025
Response to Letter to the Editor From Lin et al: "Testosterone Treatment, Weight Loss, and Health-Related Quality of Life and Psychosocial Function in Men: A 2-Year Randomized Controlled Trial"Mathis Grossmann, Kristy P Robledo, Mark Daniel, et al.
Pageof 30